Showing results for 
Search instead for 
Did you mean: 

Rapid identification of low level glycation sites in recombinant antibodies by isotopic labeling with 13C6-reducing sugars

Reputable Mentor II
Reputable Mentor II
Zhang J, Zhang T, Jiang L, Hewitt D, Huang Y, Kao YH, Katta V.
Anal Chem. 2012 Mar 6;84(5):2313-20.
Recombinant antibodies exhibit low levels of glycation from exposure to reducing sugars during production. As the glycation sites are typically distributed across the entire antibody, the levels at any one site are low and it becomes difficult to detect them in the conventional peptide maps. A model antibody was subjected to forced glycation by incubating with a high concentration of a 1:1 mixture of (12)C(6)/(13)C(6) reducing sugars with the assumption that the same sites in the native antibody will be glycated but to a lower extent. This approach simplified the detection of glycated tryptic peptide elution in the LC/MS analysis by giving a unique signature of two molecular ions with equal intensity and differing by 6.018 Da. An in-house developed script automatically processed large data files to generate a list of such peptide mass pairs. The high mass accuracy of the Orbitrap allowed us to assign the sequences unambiguously by comparison with all possible glycated peptide masses. This sequence list was subsequently used to verify their presence/absence in the digest of the native antibody. This work flow enabled rapid and confident identification of site-specific glycation even when levels are below 0.5%. We found the glycation sites to be distributed across the entire antibody studied.
Protein Analytical Chemistry, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA.
Version history
Last update:
‎10-15-2021 11:51 AM
Updated by: